Sequential chemotherapy combining Thiotepa, Etoposide and Cyclophosphamide followed by reduced-intensity conditioning in T-cell replete HLA-haploidentical hematopoietic stem cell transplantation for the treatment of refractory hematological malignancies

被引：0
|
作者：
Dulery, R. [1 ,2 ,3 ]
Menard, A. -L. [4 ]
Giannotti, F. [1 ]
Ruggeri, A. [1 ]
Brissot, E. [1 ,2 ,3 ]
Battipaglia, G. [1 ]
Belhocine, R. [1 ]
Eder, S. [1 ]
Isnard, F. [1 ]
Le Bourgeois, A. [1 ]
Rosu, A. M. [1 ]
Santoro, N. [1 ]
Mamez, A. -C. [1 ]
Lapusan, S. [1 ]
Vekhoff, A. [1 ]
Legrand, O. [1 ,2 ]
Rubio, M. -T. [1 ]
Mohty, M. [1 ,2 ,3 ]
机构：
[1] St Antoine Hosp, AP HP, Dept Hematol & Cellular Therapy, Paris, France
[2] Univ Paris 06, Paris, France
[3] INSERM, UMRs 938, Paris, France
[4] Ctr Henri Becquerel, Dept Hematol, F-76038 Rouen, France
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P455
引用
收藏
页码：S356 / S356
页数：1
相关论文
共 50 条
  • [31] Sequential Conditioning Regimen with Thiotepa in Allogeneic Hematopoietic Cell Transplantation for the Treatment of Refractory Myeloid Malignancies
    Dulery, Remy
    Belmoufid, Nadia
    Malard, Florent
    Brissot, Eolia
    Banet, Anne
    Sestili, Simona
    Van de Wyngaert, Zoe
    Stocker, Nicolas
    Radici, Vera
    Wieczorek, Michele
    Belhocine, Ramdane
    Lapusan, Simona
    Memoli, Mara
    Genthon, Alexis
    Vekhoff, Anne
    Ledraa, Tounes
    Bonnin, Agnes
    Legrand, Ollivier
    Fenaux, Pierre
    Labopin, Myriam
    Mohty, Mohamad
    BLOOD, 2021, 138 : 1796 - +
  • [32] Sequential Conditioning with Thiotepa in T Cell-Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors
    Dulery, Remy
    Menard, Anne-Lise
    Chantepie, Sylvain
    El-Cheikh, Jean
    Francois, Sylvie
    Delage, Jeremy
    Giannotti, Federica
    Ruggeri, Annalisa
    Brissot, Eolia
    Battipaglia, Giorgia
    Malard, Florent
    Belhocine, Ramdane
    Sestili, Simona
    Vekhoff, Anne
    Delhommeau, Francois
    Reman, Oumedaly
    Legrand, Ollivier
    Labopin, Myriam
    Rubio, Marie-Therese
    Mohty, Mohamad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (05) : 1013 - 1021
  • [33] Prospective study of T-cell -replete Haploidentical matched hematopoietic stem cell transplantation (HSCT) for patients with high risk hematological malignancies
    Al Dawsari, G. M.
    Mohamed, S.
    Almohareb, F.
    Chaudhri, N.
    Alsharif, F.
    Alzahrani, H.
    Rasheed, W.
    Hanbali, A.
    Shaheen, M.
    Alfraih, F.
    Elhassan, T.
    Aljurf, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S158 - S158
  • [34] Erratum: Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies
    X-J Huang
    D-H Liu
    K-Y Liu
    L-P Xu
    H Chen
    W Han
    Y-H Chen
    J-Z Wang
    Z-Y Gao
    Y-C Zhang
    Q Jiang
    H-X Shi
    D-P Lu
    Bone Marrow Transplantation, 2008, 42 : 295 - 295
  • [35] Feasibility of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens for refractory myeloid malignancies.
    Hamaki, T
    Kami, M
    Kim, SW
    Yamamoto, R
    Imataki, O
    Suyama, H
    Arima, F
    Nakai, K
    Saito, T
    Kanda, Y
    Makimoto, A
    Tanosaki, R
    Mineishi, S
    Takaue, Y
    BLOOD, 2002, 100 (11) : 851A - 851A
  • [36] Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease
    Wiebking, Volker
    Hutker, Sebastian
    Schmid, Irene
    Immler, Stefanie
    Feuchtinger, Tobias
    Albert, Michael H.
    ANNALS OF HEMATOLOGY, 2017, 96 (08) : 1373 - 1377
  • [37] HLA-haploidentical transplantation using T-cell-replete grafts and high-dose cyclophosphamide post-transplantation in the treatment of relapsed/refractory T-cell lymphoma/leukemia
    Haebe, S.
    Fraccaroli, A.
    Prevalsek, D.
    Zoellner, A-K
    Fritsch, S.
    Schulz, C.
    Ledderose, G.
    Hausmann, A.
    Dreyling, M.
    Hiddemann, W.
    Tischer, J.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S492 - S492
  • [38] Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease
    Volker Wiebking
    Sebastian Hütker
    Irene Schmid
    Stefanie Immler
    Tobias Feuchtinger
    Michael H. Albert
    Annals of Hematology, 2017, 96 : 1373 - 1377
  • [39] Cardiac Toxicity Of High Dose Cyclophosphamide Post T Cell Replete HLA Haploidentical Hematopoietic Stem Cell Transplantation
    Souchet, Laetitia
    Mayaux, Julien
    Roosweil, Damien
    Uzunov, Madalina
    Le, Alfred
    Luyt, Charles-Edouard
    Vernant, Jean Paul
    Norol, Francoise
    Treberden-Negre, Helene
    Azar, Nabih
    Lebrun-Vigne, Benedicte
    Callot, Delphine
    Boudifa, Ali
    Leblond, Veronique
    Nguyen, Stephanie
    BLOOD, 2013, 122 (21)
  • [40] IMMUNE RECONSTITUTION AFTER NONMYELOABLATIVE, T-CELL REPLETE, HLA-HAPLOIDENTICAL BMT WITH POST-TRANSPLANTATION CYCLOPHOSPHAMIDE
    Kesserwan, C.
    Munchel, A.
    Kos, F.
    Thoburn, C.
    Hess, A.
    Luznik, L.
    Kasamon, Y.
    Levitsky, H.
    Jones, R.
    Fuchs, E. J.
    Symons, H. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S230 - S231
12345